Cite
HARVARD Citation
Cheng, J. et al. (2017). Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease. Inflammatory bowel diseases. 23 (10), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cheng, J. et al. (2017). Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease. Inflammatory bowel diseases. 23 (10), p. . [Online].